Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.

CONCLUSION: PCIA is a common adverse event of breast cancer adjuvant cytotoxic chemotherapy. Clinicians should be aware of this distressing adverse event and develop supportive care strategies to counsel patients and minimize its impact on quality of life. IMPLICATIONS FOR PRACTICE: Knowledge of permanent chemotherapy-induced alopecia, an under-reported adverse event, should lead to optimized pretherapy counseling, anticipatory coping techniques, and potential therapeutic strategies for this sequela of treatment. PMID: 30120165 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30120165?dopt=Abstract

Source: The Oncologist - August 17, 2018 Category: Cancer & Oncology Authors: Kang D, Kim IR, Choi EK, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Lee HK, Park JH, Lee DY, Lacouture ME, Guallar E, Cho J Tags: Oncologist Source Type: research